Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Chenjing, Ye"'
Autor:
Ming Zhao, Jia Liu, Qing Yu, Wenbin Xu, Zilu Zhang, Ze Fu, Mingyuan Jia, Xinyi Zeng, Chengyu Wu, Chenjing Ye, Chao Wu, Yingli Wu, Ruibao Ren, Junmin Li, Kankan Wang, Hua Yan
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/95a169681de0472387c4029b7a46fb16
Publikováno v:
HemaSphere, Vol 7, p e5607975 (2023)
Externí odkaz:
https://doaj.org/article/1017e79d82364b2b9799380ee3fbbcc9
Autor:
Shaozhen Chen, Tingting Xiao, Jinhua Ren, Haojie Zhu, Chenjing Ye, Jingjing Xu, Jianda Hu, Ting Yang
Publikováno v:
HemaSphere, Vol 7, p e43634eb (2023)
Externí odkaz:
https://doaj.org/article/5e49d6b660ce470da6441064f3bb33d8
Autor:
Jinhua Ren, QiaoXian Lin, Qi Chen, Jingjing Xu, Dabin Chen, Renli Chen, Kangni Lin, Haojie Zhu, Chenjing Ye, Xiaofeng Luo, Shaozhen Chen, Hui Kong, Qiong Lin, Nan Li, Xu Lin, Zhizhe Chen, Jianda Hu, Ting Yang
Publikováno v:
iScience, Vol 26, Iss 3, Pp 106290- (2023)
Summary: Adoptive transfer of hepatitis B virus (HBV) immunity may occur following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Here, we investigated the adoptive transfer of HBV immunity in 112 patients without HBV surface antibod
Externí odkaz:
https://doaj.org/article/6dfe618ff6ec4142bf81e147ac6a0f2b
Autor:
Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Yingli Wu, Hua Yan
Publikováno v:
Cancer Biology & Medicine, Vol 19, Iss 5, Pp 651-668 (2022)
Objective: Multiple myeloma (MM) remains incurable with high rates of relapse. New therapeutic drugs are therefore urgently needed to improve the prognosis. JaponiconeA (JA), a natural product isolated from Inula japonica Thunb, has shown good anti-M
Externí odkaz:
https://doaj.org/article/fd65ac5d30d64b5e976002f439dd681f
Autor:
Yu Zhang, Chenjing Ye, Haojie Zhu, Youran Zhuang, Shaozhen Chen, Yingxi Weng, Jinhua Ren, Xiaofeng Luo, Jing Zheng, Xiaoyun Zheng, Jing Li, Lingqiong Lan, Yongxin Xie, Zhongchao Han, Jianda Hu, Ting Yang
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
ObjectivesKiller cell immunoglobulin like receptor (KIR) can trigger the alloreactivity of NK cells. However, there is no clear consensus as to their function. Here, we investigated the potential influence of KIR mismatch and KIR alleles on the outco
Externí odkaz:
https://doaj.org/article/21e28f128179423ba9020ff7823c1e7b
Autor:
Xinyi Zeng, Wenbin Xu, Jianjing Tong, Jia Liu, Zilu Zhang, Mei Liu, Chao Wu, Qing Yu, Chenjing Ye, Chengyu Wu, Yingli Wu, Hua Yan
Publikováno v:
Leukemia & Lymphoma. 63:2565-2572
SPAG5, as a spindle-associated protein in mitosis, has been observed to have oncogenic activities in solid tumors. Here, we identified that SPAG5 expression was correlated with the deterioration of plasma cell malignancy and SPAG5 overexpression (OE)
Autor:
Huaxin Song, Jiale Wu, Yigang Tang, Yuting Dai, Xinrong Xiang, Ya Li, Lili Wu, Jiaqi Wu, Ying Liang, Yangfei Xing, Ni Yan, Yuntong Li, Zhengyuan Wang, Shujun Xiao, Jiabing Li, Derun Zheng, Xinjie Chen, Hai Fang, Chenjing Ye, Yuting Ma, Yu Wu, Wen Wu, Junming Li, Sujiang Zhang, Min Lu
Publikováno v:
Science Translational Medicine. 15
Tumor suppressor p53 is inactivated by thousands of heterogeneous mutations in cancer, but their individual druggability remains largely elusive. Here, we evaluated 800 common p53 mutants for their rescue potencies by the representative generic rescu
Autor:
Ying-Li Wu, Xinyi Zeng, Chao Wu, Qing Yu, Xiaoguang Xu, Huizi Jin, Wenbin Xu, Hua Yan, Zilu Zhang, Chenjing Ye, Jia Liu
Publikováno v:
Cancer Biology & Medicine. 19:651-668
Objective: Multiple myeloma (MM) remains incurable with high rates of relapse. New therapeutic drugs are therefore urgently needed to improve the prognosis. JaponiconeA (JA), a natural product isolated from Inula japonica Thunb, has shown good anti-M
Autor:
Zilu, Zhang, Chenjing, Ye, Jia, Liu, Wenbin, Xu, Chao, Wu, Qing, Yu, Xiaoguang, Xu, Xinyi, Zeng, Huizi, Jin, Yingli, Wu, Hua, Yan
Publikováno v:
Cancer biologymedicine.
Multiple myeloma (MM) remains incurable with high rates of relapse. New therapeutic drugs are therefore urgently needed to improve the prognosis. JaponiconeA (JA), a natural product isolated fromCCK8 assays and flow cytometry were used to detect the